ProSomnus signs business combination agreement with Lakeshore
The companies expect to receive a minimum additional $10m in equity from Lakeshore's trust account or a PIPE.
Srivani Venna
Latest articles
All Articles
Quanterix receives Breakthrough Device status for multiple sclerosis test
The Simoa test can be used in conjunction with clinical, imaging and laboratory findings to identify patients with RRMS.
MicroVention begins subject enrolment in balloon guide catheter trial
The study will evaluate the safety and performance of the new balloon guide catheter to treat acute ischemic stroke.
PHC’s drug injection device receives EU-MDR certification
The device allows patients to self-inject TNF inhibitors automatically without measurement or preparation.
C2i Genomics introduces minimal residual disease test for cancer in Europe
C2inform eliminates the need for patient-specific assay development and offers a rapid solution for cancer patients.
Aatru signs distribution agreement for NPSIMS in Latin America
The disposable device needs no electromechanical pump, battery or canister and delivers advantages in ease of use.
First patient implanted in LivaNova’s trial of aura6000 System for OSA
The aura6000 System is designed to maintain the tongue’s muscle tone and features an implantable pulse generator.
Abilitech Medical secures Health Canada licence to sell orthotic device
Last year, Abilitech and the Praxis Spinal Cord Institute partnered to further scale the device for mass commercialisation.
University of Washington develops new blood-clotting test
In order to calculate the prothrombin time and international normalised ratio, the phone gathers two timestamps.